A computational biology company that started in space tech is looking to change how biopharma finds disease targets by modeling how proteins behave.
For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria—the organelles ...
Key opportunities in the protein labeling market include increasing demand for site-specific tags in proteomics and drug development, the rise of AI tools for protein structure prediction, and the ...
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site ...
Brain cells are constantly swallowing material from the fluid that surrounds them - signaling molecules, nutrients, even ...
Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting ...
Professor Chad Mirkin found that the vaccine’s carefully organized structure dramatically boosts cancer-fighting immunity.
A new preclinical study has shown that reducing the protein HDAC11 could slow muscle degeneration in Duchenne muscular dystrophy, providing a potential target for future therapies.
AI pioneer Vishal Sikka warns to never trust an LLM that runs alone interview Don't trust; verify. According to AI researcher ...
A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.
Last year, people in the U.S. made an estimated $4.7 billion selling their plasma. Donation centers are popping up in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results